Evidence map›Paper›PMID 40707549›Full record

ArticleScientific reports2025

Development and validation of a prognostic model for nasal cavity squamous cell carcinoma based on the SEER database.

Qiwei Zeng, Ming Sheng, Si Ouyang, Bin Liu

Abstract readValidation Study
PubMed Full text at PMC Publisher
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Qiwei Zeng *Department of Otorhinolaryngology - Head and Neck Surgery, The First Affiliated Hospital of Hunan Normal University Hunan Provincial People's Hospital, Changsha, 410005, China.
Ming Sheng *Department of Otorhinolaryngology - Head and Neck Surgery, The First Affiliated Hospital of Hunan Normal University Hunan Provincial People's Hospital, Changsha, 410005, China.
Si Ouyang *Department of Otorhinolaryngology - Head and Neck Surgery, The First Affiliated Hospital of Hunan Normal University Hunan Provincial People's Hospital, Changsha, 410005, China.
Bin LiuDepartment of Otorhinolaryngology - Head and Neck Surgery, The First Affiliated Hospital of Hunan Normal University Hunan Provincial People's Hospital, Changsha, 410005, China. liu15116305310@126.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study sought to construct and validate a prognostic nomogram for predicting cause-specific survival (CSS) in patients with nasal cavity squamous cell carcinoma (NCSCC). We conducted a retrospective analysis of clinical data from NCSCC patients registered in the SEER database between 2007 and 2015. Statistical analyses were performed to assess CSS rates and identify prognostic factors. The study cohort comprised 580 NCSCC patients, with CSS probabilities of 89.1%, 74.8%, and 63.6% at 1, 3, and 5 years, respectively. Multivariate Cox regression analysis identified age, American Joint Committee on Cancer (AJCC) stage, and radiotherapy administration as independent prognostic factors significantly associated with CSS. The accuracy of the prediction was evaluated using the C-index and calibration curve. Decision curve analysis (DCA) was utilized to compare the nomogram with the AJCC stage system in order to assess its superiority. We developed and validated a predictive model for 1-, 3-, and 5-year CSS in NCSCC based on a large retrospective cohort. The nomogram demonstrates clinical utility in guiding individualized treatment strategies and patient management.

Indexed as

Carcinoma, Squamous CellNasal CavityNose NeoplasmsAdultAgedAged, 80 and overFemaleHumansMaleMiddle AgedNeoplasm StagingNomogramsPrognosisRetrospective StudiesSEER ProgramNasal cavity squamous cell carcinomaNomogramPrognostic modelSEER database

Identifiers

PMID40707549
PMCPMC12289908

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.